Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6919705 | 7537280 | F | 6919705-3 | 20100501 | 20100513 | 20100811 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-15101041 | BRISTOL-MYERS SQUIBB COMPANY | 55 | YR | F | Y | 20100811 | OT | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6919705 | 1014395007 | PS | IXEMPRA KIT | 1 | INTRAVENOUS | CYCLE 1 (FROM 25-MAR-10):60 MG; ON 26APR2010 (CYCLE 2) DOSE REDUCED TO 45 MG (IV Q3 WEEKS) | 022065 | ||||
| 6919705 | 1014395008 | SS | XELODA | 1 | ORAL | 14 OF 21 DAYS |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6919705 | 1014395007 | BREAST CANCER METASTATIC |
| 6919705 | 1014395008 | BREAST CANCER METASTATIC |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6919705 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6919705 | ANAEMIA |
| 6919705 | BONE MARROW FAILURE |
| 6919705 | DIARRHOEA |
| 6919705 | DIZZINESS |
| 6919705 | HYPOKALAEMIA |
| 6919705 | HYPOTENSION |
| 6919705 | PYREXIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6919705 | 1014395007 | 20100325 |